Diagnostic performance of clinical properties and conventional magnetic resonance imaging for determining the IDH1 mutation status in glioblastoma: a retrospective study
Background Glioblastoma (GBM), the most malignant form of gliomas, is a relatively common primary brain tumor in adults. Preoperative identification of isocitrate dehydrogenase 1 (IDH1) mutations in GBM is of critical prognostic importance. The aim of the present study was to explore the feasibility...
Main Authors: | Qun Wang, Jiashu Zhang, Fangye Li, Xinghua Xu, Bainan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-06-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/7154.pdf |
Similar Items
-
<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01) -
Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
by: Christine Jungk, et al.
Published: (2019-01-01) -
Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma
by: Kang H, et al.
Published: (2020-10-01) -
The role of IDH1/2 mutations in the pathogenesis of secondary glioblastomas
by: Eduardo Cambruzzi
Published: (2017-10-01) -
Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
by: Ali S. Haider, et al.
Published: (2023-04-01)